Pancreatic Cancer Research

ResearcherCenter for Biologics Evaluation and ResearchNo recent work listed

Raj K. Puri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2548-346X; OpenAlex author ID A5067972591. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 6

  1. IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Co-author DOI 10.3390/diagnostics11071140↗
  2. A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers12051294↗
  3. Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients Last author DOI 10.1186/2051-1426-3-s2-p88↗
  4. Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer. Last author DOI 10.1371/journal.pone.0034437↗
  5. Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine. Last author DOI 10.1002/ijc.25437↗
  6. Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer. Last author DOI 10.1186/1479-5876-9-37↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshio Fujisawa · 6 shared papers, 2011–2021 · strength 0.39
  2. Hiroyuki Isayama · 2 shared papers, 2020–2021 · strength 0.21
  3. Yusuke Takasaki · 1 shared paper, 2021 · strength 0.12
  4. Ko Tomishima · 1 shared paper, 2021 · strength 0.12
  5. Atsushi Nakajima · 2 shared papers, 2011–2020 · strength 0.12
  6. Yoshinori Ino · 1 shared paper, 2020 · strength 0.09
  7. Naoya Kato · 1 shared paper, 2020 · strength 0.09
  8. Shin Maeda · 1 shared paper, 2020 · strength 0.09
  9. Itaru Endo · 1 shared paper, 2020 · strength 0.09
  10. William Allen Gahl · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.